Clinical Trial Update: Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing novel epothilone plus capecitabine versus capecitabine alone in advanced/metastatic breast cancer completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Epothilone (epothilone)

Snippet

Sponsor: R-Pharm | Conditions: Breast Cancer, Metastases | Phase 3 | Status: COMPLETED | Results posted: 2009-08-17